Kamal Gandotra, MD

Division of Pulmonary, Critical Care and Sleep Medicine, University Hospitals, Case Western Reserve University, Cleveland, Ohio; Psychiatry Service, Louis Stokes VA Medical Center, Cleveland, Ohio; Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio; Division of Pulmonary, Critical Care, and Sleep Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio

  • 2Articles
  • 90.7KReads1
  • 2021–2026Active
  • 18Collaborators
  • 5Citations2

About

Kamal Gandotra, MD, is affiliated with the Division of Pulmonary, Critical Care and Sleep Medicine at University Hospitals and Louis Stokes VA Medical Center, as well as the Department of Psychiatry at Case Western Reserve University in Cleveland, Ohio. Gandotra has published research on sleep disorders, focusing on the treatment and development of insomnia related to medications such as mirtazapine and bupropion. The work appeared in Psychiatrist.com between 2021 and 2026. Frequent collaborators include Brigid Wilson, Amal Rubai, Elizabeth Zink, Eric Konicki, and George E. Jaskiw.

Publications

PCC
Ultra–Low-Dose Mirtazapine for Chronic Insomnia
Original Research

Ultra–Low-Dose Mirtazapine for Chronic Insomnia

March 10, 2026

In patients with insomnia disorder, a clinically relevant effect was seen with low-dose mirtazapine (3.75 mg) on insomnia severity from 1–3 months.
, , , et al
PCC
Brief Report

Insomnia Associated With Bupropion Formulations

February 18, 2021

In this brief report, the authors evaluate the effects of a possible association between different bupropion formulations and treatment-emergent insomnia in veterans with major depressive disorder prescribed bupropion based...
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe